Comanche Biopharma

About:

Our purpose is to make every pregnancy around the world safer.

Website: https://comanchebiopharma.com

Top Investors: F-Prime Capital, New Enterprise Associates, Google Ventures, Lilly Asia Ventures, Atlas Venture

Description:

Comanche is a biopharmaceutical company developing an investigational siRNA medicine for preterm preeclampsia. We envision a world where all women and their babies have access to safe and effective therapies for treating life threatening complications of pregnancy, and those solutions must be evidence-based and affordable.

Total Funding Amount:

$111M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Concord, Massachusetts, United States

Founded Date:

2020-01-01

Founders:

Mike Young, Thomas Scott Johnson

Number of Employees:

11-50

Last Funding Date:

2024-01-17

IPO Status:

Private

Industries:

© 2025 bioDAO.ai